SCHEMBL4981966

SCHEMBL4981966

CC(C)(C)OP(=O)(S)OC(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11735580 0.85 ALDH1A1 (0.30)
SCHEMBL11622158 0.75 MEN1 (0.34)
SCHEMBL13976469 0.75
SCHEMBL486485 0.72 TSHR (0.31)
SCHEMBL13978284 0.71 TSHR (0.31)
SCHEMBL3346640 0.71 ALDH1A1 (0.33)
SCHEMBL6744443 0.71
SCHEMBL517524 0.69
SCHEMBL4253621 0.69
SCHEMBL12604843 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240229026-A1 CHIRAL CONTROL WAVE LIFE SCIENCES LTD. (SG) 2024-07-11 US disclosed
US-20230304012-A1 MUSCLE REGENERATION AND GROWTH NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2023-09-28 US disclosed
US-20230295617-A1 METHODS AND COMPOSITIONS OF BIOLOGICALLY ACTIVE AGENTS WAVE LIFE SCIENCES LTD. (SG) 2023-09-21 US disclosed
US-11739325-B2 Oligonucleotide compositions and methods thereof WAVE LIFE SCIENCES LTD. (SG) 2023-08-29 US disclosed
US-11643657-B2 Chiral control WAVE LIFE SCIENCES LTD. (SG) 2023-05-09 US disclosed
US-20180216108-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF WAVE LIFE SCIENCES LTD. (SG) 2018-08-02 US disclosed
US-20180216107-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF WAVE LIFE SCIENCES LTD. (SG) 2018-08-02 US disclosed
US-9982257-B2 Chiral control WAVE LIFE SCIENCES LTD. (SG) 2018-05-29 US disclosed
US-9885037-B2 2018-02-06 US disclosed
US-20170275621-A1 CHIRAL CONTROL WAVE LIFE SCIENCES USA, INC. 2017-09-28 US disclosed
US-20170037399-A1 CHIRAL DESIGN WAVE LIFE SCIENCES LTD. (SG) 2017-02-09 US disclosed
US-20150211006-A1 CHIRAL CONTROL WAVE LIFE SCIENCES USA, INC. 2015-07-30 US disclosed
US-20080076736-A1 COMPOSITIONS CONTAINING LYSOPHOSPHATIDIC ACIDS WHICH INHIBIT APOPTOSIS AND USES THEREOF SKY HIGH, LLC (US) 2008-03-27 US disclosed
US-7259273-B1 Compositions containing lysophosphotidic acids which inhabit apoptosis and uses thereof GODDARD JOHN G 2007-08-21 US disclosed
EP-1024812-B1 COMPOSITIONS CONTAINING LYSOPHOSPHATIDIC ACIDS WHICH INHIBIT APOPTOSIS AND USES THEREOF SKY HIGH LLC (US) 2007-01-24 EP disclosed
US-20060063738-A1 Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof SKY HIGH, LLC (US) 2006-03-23 US disclosed
US-6949528-B1 Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof GODDARD JOHN G 2005-09-27 US disclosed
US-6949529-B2 Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof SKY HIGH, LLC (US) 2005-09-27 US disclosed
US-20030149002-A1 Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof SKY HIGH, LLC. 2003-08-07 US disclosed
US-6495532-B1 PRESERVATION AND TREATMENT OF ORGANS FOR TRANSPLANTATION WITH SUCH AS 3-OLEOYL-2-METHYL-1-THIOPHOSPHATE-GLYCERIDE AND A POTENTIATING COPONENT SUCH AS POLYETHYLENE GLYCOL, A PROTEIN OR A LIPID MEMBRANE SKY HIGH, LLC 2002-12-17 US disclosed